Hyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has received a GMP ...

CuraTeQ Biologics' EMA GMP certification marks a key milestone in Aurobindo Pharma's expansion into biosimilars, with three ...

Aurobindo Pharma's Hyderabad-based biosimilars facility receives GMP certification from the European Medicines Agency, paving ...

Aurobindo Pharma witnessed an 8.6% YoY increase in net profit, reaching Rs 817 crore in Q2 FY25, driven by robust sales in ...

Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 1475 in its research report ...

Aurobindo Pharma's CuraTeQ Biologics receives EMA GMP certificate for biosimilars, paving way for European approvals of three ...

Aurobindo Pharma’s revenue was in-line with our estimates. However, EBITDA and Adj. PAT missed our estimates due to higher ...

Aurobindo Pharma consolidated net profit for the September quarter increased 8.6% to ₹816.9 crore compared to ₹751.9 crore year earlier. On a sequential basis the net profit was 11% lower, from ₹918.2 ...

Chinese pharmaceutical giant Shanghai Pharmaceuticals Holding Co. Ltd is keen on importing active pharmaceutical ingredients ...

F&O data shows, on Friday Aarti Industries, Aurobindo Pharma and Trent saw a dip in share price alongside rise in open ...

Aurobindo Pharma witnessed a nearly 9% surge in consolidated net profit for Q2FY25, reaching Rs 817 crore. This growth was fueled by an 8% rise in con ...

Aurobindo Pharma posted an 8.6 per cent increase in net profit for the second quarter of fiscal year 2025, reaching Rs 817 ...